(3-羧丙基)三苯基溴化膦

• 产品号: 349720
• CAS号: 17857-14-6
• 分子式: C22H22BrO2P
• 分子量: 429.286641
• 纯 度: 98%

产品别名

• 标题: (3-Carboxypropyl)triphenylphosphonium bromide
• IUPAC标准名: (3-carboxypropyl)triphenylphosphanium bromide
• IUPAC传统名: (3-carboxypropyl)triphenylphosphanium bromide
• 别名: (4-Hydroxy-4-oxobutyl)triphenylphosphonium bromide

产品登记号

• CAS号: 17857-14-6
• MDL号: MFCD00274196
• PubChem SID: 24861704

产品性质

• 线性分子式: HO2C(CH2)3P(C6H5)3Br
• 纯度: 98%
• 熔点: 244-247 °C(lit.)
• GHS警示词: Warning
• GHS危险声明: H315-H319-H335
• 欧盟危险性物质标志: 刺激性(Irritant) (Xi)
• 个人保护装置: dust mask type N95 (US), Eyeshields, Gloves
• GHS警示性声明: P261-P305 + P351 + P338
• 危险公开号: 36/37/38
• 安全公开号: 26-36
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Packaging
25, 100 g in glass bottle
Application
Reactant for preparation of:
• Piperamide analogs as histone deacetylase (HDAC) inhibitors with antitumor activity1
• Boron-containing benzoxaboroles as antimalarial agents2
• Methyl alkenyl quinolones as antimycobacterial agents3
• Solandelactone E via Sharpless epoxidation, Taber cyclopropanation, chemoselective reductions and lithiation-borylation-allylation sequence4
• Organotin compounds as antifungal agents5
• Oleanolic acid derivatives as inhibitors of protein tyrosine phosphatase 1B for negative regulation of insulin pathway (a promising target for treatment of diabetes and obesity)6
• 11-oxa prostaglandin analogs with ocular hypotensive activity7

详细说明 (简体中文)

包装
25, 100 g in glass bottle
Application
Reactant for preparation of:
• Piperamide analogs as histone deacetylase (HDAC) inhibitors with antitumor activity1
• Boron-containing benzoxaboroles as antimalarial agents2
• Methyl alkenyl quinolones as antimycobacterial agents3
• Solandelactone E via Sharpless epoxidation, Taber cyclopropanation, chemoselective reductions and lithiation-borylation-allylation sequence4
• Organotin compounds as antifungal agents5
• Oleanolic acid derivatives as inhibitors of protein tyrosine phosphatase 1B for negative regulation of insulin pathway (a promising target for treatment of diabetes and obesity)6
• 11-oxa prostaglandin analogs with ocular hypotensive activity7